In vivo and in vitro immunological cross-reactions between basic encephalitogen and synthetic basic polypeptides capable of suppressing experimental allergic encephalomyelitis-Reference-Cited by-同舟云学术

In vivo and in vitro immunological cross-reactions between basic encephalitogen and synthetic basic polypeptides capable of suppressing experimental allergic encephalomyelitis

Published:1973-05 Issue:5 Volume:3 Page:279-286
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Webb Cynthia,Teitelbaum Dvora,Arnon Ruth,Sela M.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference31 articles.

1. Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide

2. Suppression by several synthetic polypeptides of experimental allergic encephalomyelitis induced in guinea pigs and rabbits with bovine and human basic encephalitogen

3. Experimental Allergic Encephalomyelitis and Autoimmune Disease

4. Immune Processes and Infectious Factors in Central Nervous System Disease

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the In Vitro Potential of Glatiramer Acetate (Copaxone®) as a Chemotherapeutic Candidate for the Treatment of Cryptococcus neoformans Infection;Journal of Fungi;2023-07-25

2. B-Cell Activity Predicts Response to Glatiramer Acetate and Interferon in Relapsing-Remitting Multiple Sclerosis;Neurology - Neuroimmunology Neuroinflammation;2021-03-11

3. Targets and Mechanisms in Prevention of Parkinson's Disease through Immunomodulatory Treatments;Scandinavian Journal of Immunology;2017-04-24

4. Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis;Journal of Translational Medicine;2016-05-01

5. Mechanisms of Action of Glatiramer Acetate in the Treatment of Multiple Sclerosis;Multiple Sclerosis;2016